AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
My Activity
EN
Login
EN
Surge Analysis
/
Daewon Pharmaceutical Co., Ltd.
/
2026-06-05
▲ SURGE
Daewon Pharmaceutical Co., Ltd.
+29.9%
003220
KRX
Healthcare
2026-06-05
11,240
Close
8,650
Prev Close
+29.94%
Change
0.7x
Vol Ratio
Why It Surged
No related news available.
Related News
ImmuneOnco Completes Key Patient Enrollment in Phase III Trial of Lead Cancer Drug IMM01
Tipranks
2026-03-22
Aurobindo Pharma Announcements/Notices: Latest Sotck/Share Market Notices/Announcements on Aurobindo Pharma, Aurobindo Pharma Stock Split,Bonus, Rights, Re-Structuring, Dividends, Board Meetings, Quarterly Results, Record Date, Ex-Date, Book Closure on BSE/NSE
Moneycontrol
2026-04-08
Takeda Pharmaceutical Co Sees FY2026 Adj EPS $3.01; Sees Sales $29.585B - Takeda Pharmaceutical Co (NYSE:
Benzinga
2026-05-13
Takeda Pharmaceutical Co Sees FY2026 GAAP EPS $0.66. - Takeda Pharmaceutical Co (NYSE:TAK)
Benzinga
2026-05-13
D3 Energy Plans New Share Placement and Options Issue
Tipranks
2026-03-22
Technical Analysis
No technical analysis available.
View Company
Back to Surge Stocks
Home
Chat
Portfolio
Activity
Menu
Daewon Pharmaceutical Co., Ltd. Surged +29.9% on 2026-06-05 — Analysis | Alpha Lenz